The loss of the BIN1 tumor suppressor is among the most common oncogenic drivers across various cancers, including esophageal, gastric, neuroblastoma, breast, lung, colorectal, prostate, pancreatic cancers, and malignant pleural mesothelioma [16, 17]. This evidence concerns the gene BIN1 and cancer.